CANNALEAN
CannaLean is an R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipidemia. The company is committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit millions of patients suffering from Dyslipidemia. CannaLean's preliminary results show the effect of the formulation of cholesterol and triglyceride reduction. It uses a synthetic form of CBD, a non-psychotropic component of cannabis, with chitosan, a biocompatible, non-toxic, and non-immunogenic compound that enhances the potential of CBD to reduce lipid blood levels. CannaLean was founded in 2017 and is headquartered in Bene Beraq, Israel.
CANNALEAN
Social Links:
Industry:
Biotechnology Cannabis Medical
Founded:
2017-01-01
Address:
Bene Beraq, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.cannaleanbio.com
Total Employee:
1+
Status:
Active
Contact:
(972) 3 617 6644
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Analytics Apple Mobile Web Clips Icon WordPress Font Awesome Apache Mobile Non Scaleable Content Sitelinks Search Box
Similar Organizations
Current Employees Featured
Official Site Inspections
http://www.cannaleanbio.com
- Host name: 185.60.170.211
- IP address: 185.60.170.211
- Location: Israel
- Latitude: 31.5
- Longitude: 34.75
- Timezone: Asia/Jerusalem
More informations about "CannaLean"
Cannalean BiotechsCannalean Biotechs - | About CannaLean …
Cannalean Biotechs Ltd. founded in 2017 and headquartered in Israel, is a company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and …See details»
Who Am I? - cannaleanbio.com
Cannalean Biotechs Ltd. founded in 2017 and headquartered in Israel, is a company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and …See details»
CannaLean - Crunchbase Company Profile & Funding
Organization. CannaLean . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number (972) 3 …See details»
CannaLean Company Profile 2024: Valuation, Funding …
CannaLean General Information Description. Developer of a novel proprietary formulation intended to serve patients suffering from Dyslipidemia. The …See details»
Cannalean Biotechs - Company Profile - Tracxn
Nov 27, 2024 Cannalean Bio is a provider of cannabidiol and chitosan-based formulation for dyslipidemia. The company offers proprietary formulation which reduces the LDL cholesterol …See details»
CannaLean Biotechs - LinkedIn
CannaLean Biotechs | 97 followers on LinkedIn. An R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipidemia | CannaLean Biotechs Ltd., founded in 2017 ...See details»
Cannalean Biotechs - Foreign Startup | Startup Nation Finder
Note that you need to have an email in this organization in order to claim the profile. Name* Work Email* (please provide your email in the organization) Position* Notes. Send Create Free …See details»
CannaLean - Contacts, Employees, Board Members, Advisors
CannaLean is an R&D company developing CBD based solutions to benefit millions of patients suffering from Dyslipidemia.See details»
Cannalean BiotechsCannalean Biotechs - | CANNALEAN Biotech’s …
Twice awarded with the President Excellency Award for serving the community and managed the Israeli branch of AIESEC organization where he got the hall of fame award. Mr. Bassa holds a …See details»
CannaLean Biotechs Announces a Phase 2a Clinical Trial of
TEL AVIV, Israel, June 21, 2022 /PRNewswire/ -- CannaLean Biotechs is happy to announce “first patient in,” under its phase 2a, randomized, double-blind, placebo-controlled, multicenter …See details»
CannaLean Develops New Cannabidiol & Chitosan Formulation to …
Dec 13, 2018 Potential investors, M&A, research partners can contact CannaLean at www.cannaleanbio.com . For further information contact: [email protected], (972) 3 617 6173. …See details»
CannaLean Develops New Cannabidiol & Chitosan Formulation to …
Nov 26, 2018 Potential investors, M&A, research partners can contact CannaLean at www.cannaleanbio.com For further information contact: [email protected] , +972- 3-617-6173. …See details»
CannaLean Biotechs Announces a Phase 2a Clinical Trial of …
TEL AVIV, Israel, June 21, 2022 /PRNewswire/ -- CannaLean Biotechs is happy to announce "first patient in," under its phase 2a, randomized, double-blind,See details»
Cannalean BiotechsCannalean Biotechs - | Contact CANNALEAN …
Cannalean Biotechs Ltd. founded in 2017 and headquartered in Israel, is a company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and …See details»
CannaLean Biotechs | CipherBio
Explore CannaLean Biotechs's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
CannaLean Develops New Cannabidiol & Chitosan Formulation to …
Nov 26, 2018 CannaLean, an Israeli company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and Chitosan that will potentially benefit …See details»
Cannalean BiotechsCannalean Biotechs - | CANNALEAN’S Partners
Cannalean Biotechs Ltd. founded in 2017 and headquartered in Israel, is a company committed to the research and development of a novel proprietary formulation of Cannabidiol (CBD) and …See details»
Cannalean BiotechsCannalean Biotechs - | CANNALEAN CBD …
The burden of morbidity, mortality, and the medical costs arising from Dyslipidemia is substantial – Dyslipidemia is responsible for nearly 20% of the global burden of cerebrovascular disease, …See details»
CannaLean Biotechs Announces a Phase 2a Clinical Trial of …
TEL AVIV, Israel, June 21, 2022 /PRNewswire/ -- CannaLean Biotechs is happy to announce "first patient in," under its phase 2a, randomized, double-blind, placebo-controlled, multicenter …See details»